162 related articles for article (PubMed ID: 21265816)
1. Probing cationic selectivity of cardiac calsequestrin and its CPVT mutants.
Bal NC; Jena N; Sopariwala D; Balaraju T; Shaikh S; Bal C; Sharon A; Gyorke S; Periasamy M
Biochem J; 2011 Apr; 435(2):391-9. PubMed ID: 21265816
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human cardiac calsequestrin and its deleterious mutants.
Kim E; Youn B; Kemper L; Campbell C; Milting H; Varsanyi M; Kang C
J Mol Biol; 2007 Nov; 373(4):1047-57. PubMed ID: 17881003
[TBL] [Abstract][Full Text] [Related]
3. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
[TBL] [Abstract][Full Text] [Related]
4. Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: a simulation study of cellular mechanism.
Faber GM; Rudy Y
Cardiovasc Res; 2007 Jul; 75(1):79-88. PubMed ID: 17531962
[TBL] [Abstract][Full Text] [Related]
5. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.
Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S
Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535
[TBL] [Abstract][Full Text] [Related]
6. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling.
Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J
J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875
[TBL] [Abstract][Full Text] [Related]
7. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
[TBL] [Abstract][Full Text] [Related]
8. Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin.
Valle G; Galla D; Nori A; Priori SG; Gyorke S; de Filippis V; Volpe P
Biochem J; 2008 Jul; 413(2):291-303. PubMed ID: 18399795
[TBL] [Abstract][Full Text] [Related]
9. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG
J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358
[TBL] [Abstract][Full Text] [Related]
10. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
Dirksen WP; Lacombe VA; Chi M; Kalyanasundaram A; Viatchenko-Karpinski S; Terentyev D; Zhou Z; Vedamoorthyrao S; Li N; Chiamvimonvat N; Carnes CA; Franzini-Armstrong C; Györke S; Periasamy M
Cardiovasc Res; 2007 Jul; 75(1):69-78. PubMed ID: 17449018
[TBL] [Abstract][Full Text] [Related]
11. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
[TBL] [Abstract][Full Text] [Related]
12. Calsequestrin and the calcium release channel of skeletal and cardiac muscle.
Beard NA; Laver DR; Dulhunty AF
Prog Biophys Mol Biol; 2004 May; 85(1):33-69. PubMed ID: 15050380
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia.
di Barletta MR; Viatchenko-Karpinski S; Nori A; Memmi M; Terentyev D; Turcato F; Valle G; Rizzi N; Napolitano C; Gyorke S; Volpe P; Priori SG
Circulation; 2006 Sep; 114(10):1012-9. PubMed ID: 16908766
[TBL] [Abstract][Full Text] [Related]
14. Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.
Faggioni M; Kryshtal DO; Knollmann BC
Pediatr Cardiol; 2012 Aug; 33(6):959-67. PubMed ID: 22421959
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes.
Kubalova Z; Györke I; Terentyeva R; Viatchenko-Karpinski S; Terentyev D; Williams SC; Györke S
J Physiol; 2004 Dec; 561(Pt 2):515-24. PubMed ID: 15486014
[TBL] [Abstract][Full Text] [Related]
16. The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.
Zhang J; Chen B; Zhong X; Mi T; Guo A; Zhou Q; Tan Z; Wu G; Chen AW; Fill M; Song LS; Chen SR
Biochem J; 2014 Jul; 461(1):99-106. PubMed ID: 24758151
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
Laitinen PJ; Swan H; Kontula K
Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.
Kalyanasundaram A; Viatchenko-Karpinski S; Belevych AE; Lacombe VA; Hwang HS; Knollmann BC; Gyorke S; Periasamy M
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H253-61. PubMed ID: 21984545
[TBL] [Abstract][Full Text] [Related]
19. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.
Knollmann BC; Chopra N; Hlaing T; Akin B; Yang T; Ettensohn K; Knollmann BE; Horton KD; Weissman NJ; Holinstat I; Zhang W; Roden DM; Jones LR; Franzini-Armstrong C; Pfeifer K
J Clin Invest; 2006 Sep; 116(9):2510-20. PubMed ID: 16932808
[TBL] [Abstract][Full Text] [Related]
20. Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants.
Valle G; Arad M; Volpe P
J Muscle Res Cell Motil; 2020 Sep; 41(2-3):251-258. PubMed ID: 32902830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
